Instalab
logoInstalab

Fat Mass (Arms)

See whether upper-body storage is outpacing muscle, an early clue to metabolic risk in research cohorts.
4.9 (4,001 reviews)
Physician-reviewed results
How it works
Order from Instalab
No prescription or your own doctor's order needed
Get blood drawn
At home
Get results
Explained with clear next steps, no medical jargon

Should you take a Fat Mass (Arms) test?

This test is most useful if any of these apply to you.

Healthy but Want to Stay Ahead
See where stored weight sits and track whether it is changing while your blood markers still look normal.
Told Your Blood Sugar Is Borderline
More upper-limb fat relative to muscle predicted diabetes in large studies, regardless of BMI.
Losing Weight on Purpose
A regional scan shows whether the pounds you lose are coming off as fat while muscle holds steady.
Over 60 and Watching Strength
Track whether fat and muscle reserves are holding steady, especially during illness or weight loss.

About Fat Mass (Arms)

Two people can weigh the same and still carry different odds of type 2 diabetes and heart disease, and part of the difference is where their fat sits. For this marker, the evidence is strongest when the pounds value is read with arm muscle, total fat, visceral fat, and blood markers. Most outcome studies did not use the pounds value by itself. They used arm fat-to-muscle ratio, arm fat percentage, or triceps skinfold, a skin-pinch measure of the fat layer at the back of the upper arm.

This is a regional body-composition result, not a blood marker. There are no agreed clinical cutoffs yet, and what the number means shifts with age, sex, total body size, and how much muscle you carry. A baseline followed by a method-consistent trend is usually more useful than one isolated result.

What the Number Captures

Most of the fat in your arms is subcutaneous fat, the layer just under the skin. It is usually less harmful than visceral fat, which sits around the abdominal organs. Fat tissue is not only storage, though. In excess it releases inflammatory signaling proteins that can push the body toward insulin resistance. That means your cells respond less well to the hormone that clears sugar from your blood.

Most of the strongest research reads arm fat against arm muscle instead of on its own. Researchers call this the arm fat-to-muscle ratio: the amount of fat in the arms divided by the amount of muscle there. The ratio matters because muscle is where much of insulin-driven sugar uptake happens, so it compares the load against the capacity to handle it. If your report also includes arm lean mass, you can read the two together.

Outcome studies have measured regional body composition with DXA scans, segmental bioelectrical impedance, skinfolds, or other body-composition methods. Those methods are not interchangeable. A result from one device or platform should be compared with future results from the same method whenever possible.

Arm fat varies a lot between men and women, so published reference values are split by sex and age. Genes play a part too. A large study of fat distribution found 98 DNA regions that influence where fat is stored, 37 of them with stronger effects in women, and a separate study tied a protein-coding variant to arm fat in particular.

Type 2 Diabetes

The diabetes link is the most consistent finding. Among about 465,000 UK adults followed for 11 years, higher fat-to-muscle ratios in each body region, arms included, predicted new type 2 diabetes even after BMI was taken into account. The link was steepest in people who were already overweight. In that group, people in the top third for these ratios had several times the diabetes risk of the comparison group, with hazard ratios between 5.91 and 7.94 depending on the region.

Where arm fat sits relative to leg fat matters as well. In a survey of about 13,000 Korean adults, people carrying the most fat in their arms compared with their legs had roughly 7 times the odds of diabetes in men and 10 times the odds in women. That study took a single snapshot, so it shows a strong association without showing which came first.

  • Multiple chronic diseases: in a UK cohort of about 383,000 adults, a higher arm fat percentage raised men's risk of developing two or more chronic conditions by 19.4%.
  • Blood pressure, cholesterol, and glucose: in about 12,000 US adults, more upper-limb fat went with modestly higher odds of hypertension, high cholesterol, and diabetes, while more upper-limb lean mass went with lower odds.
  • Age: in a Chinese national survey of about 13,500 adults, the link between higher arm fat-to-muscle ratio and clustered cardiometabolic risk factors was stronger in younger people.
  • People who already have diabetes: among about 2,400 adults with type 2 diabetes, more arm fat went with higher odds of elevated LDL cholesterol.

If your arm fat is high relative to your arm muscle, check the blood markers that show insulin resistance directly: fasting insulin, glucose, and HbA1c. A high ratio alongside rising insulin is a stronger reason to act than either number alone.

Heart Disease

In about 469,000 UK adults without heart disease at the start, men in the highest quarter for arm fat-to-muscle ratio had more heart attacks, strokes, and cardiovascular deaths over 12.5 years than men in the lowest quarter. The trend held after adjustment for demographics and lifestyle. Part of the link ran through small blood chemicals and inflammatory cells, which fits the idea that excess fat changes blood chemistry.

The pattern is sharper in people who already have type 2 diabetes. Among about 21,500 of them followed for 7.7 years, cardiovascular risk rose in a straight line with arm fat percentage, and the top quarter had about 63% higher risk than the bottom quarter. Leg fat ran the other way and was linked to lower risk.

A UK analysis of about 424,000 people over 13.5 years tracked how they moved from healthy, to a first cardiometabolic disease, to death. Upper-body fat, arms included, was linked to faster progression along that path, while leg fat appeared protective in the step from first disease to death. Fat in your arms and fat in your legs seem to carry different meanings, so a result that separates regions tells you more than a total alone.

Longevity and the Two Faces of Arm Fat

The mortality data look contradictory at first. Some studies find more arm fat means higher death risk, and others find less arm fat does. The three cohorts below show both directions.

Who Was StudiedWhat Was ComparedWhat They Found
About 338,000 UK adults followed for 12.6 yearsHighest vs lowest fifth of arm fat-to-muscle ratioMen in the top fifth had about 14% higher death risk, with risk rising most steeply at the high end
4,000 older Chinese adults followed for a median of 18.2 yearsLowest vs middle third of arm fat-to-lean ratioMen with the least arm fat relative to lean mass had higher death risk
About 17,700 Chinese adultsThickest vs thinnest skinfold at the back of the upper armThe thickest group had about 30% lower death risk, independent of BMI

Both findings make sense once you see that arm fat carries two different signals depending on who is carrying it. When someone has more fat overall than their muscle can handle, extra arm fat reflects that surplus and tracks metabolic disease. In older adults and people with chronic illness, the fat under the arm skin can also be an energy reserve, and losing it can signal illness or poor nutrition. Among about 1,000 people on dialysis, those whose arm skinfold held up best over 48 months had about 60% lower death risk than those whose skinfold fell, regardless of their BMI trend.

Adjustment changes the picture too. In a DXA study of about 5,000 people, once total body fat was accounted for, arm fat in men showed favorable links with diabetes and heart risk markers, possibly because it works as a safer storage place than the trunk. A US survey of about 14,400 adults similarly found arm fat tied to lower diastolic blood pressure after full adjustment. Read your number against total fat, visceral fat, arm muscle, and age, and treat the direction it is moving in as more informative than its absolute size.

Among older US adults with type 2 diabetes, the top quarter for arm fat mass index had about 80% higher risk of dying from causes other than heart disease, after accounting for arm muscle and other factors. It was not linked to cardiovascular death in that group, and the risk was concentrated in current and former smokers.

Bones, Joints, Lungs, and Brain

  • Fractures: among about 212,000 UK adults aged 60 and older, those in the top fifth for arm fat-to-muscle ratio had about 24% higher risk of a major osteoporotic fracture than the bottom fifth, even after adjustment for BMI and estimated bone density.
  • Osteoarthritis: in about 329,000 UK adults followed for 14.4 years, higher arm fat-to-muscle ratios carried modestly higher osteoarthritis risk, about 6% in men and 11% in women for each typical step up, independent of BMI.
  • Asthma: a genetic study that used inherited variants as a natural experiment found that higher arm fat was linked to higher risk of adult asthma.
  • Brain health: in about 413,000 UK adults, an arm-dominant fat pattern was linked to 13% to 18% higher rates of neurodegenerative disease, and cardiovascular disease explained between 10.7% and 35.3% of that link.

A UK study of about 436,000 cancer-free adults also found that total and regional fat-to-muscle ratios, including the arm ratio, were associated with overall cancer risk and several specific cancers. For you, this means a high arm ratio is less a single-organ warning than a sign of a whole-body pattern worth correcting.

When Results Can Be Misleading

Regional measurements are noisier than whole-body ones, and that matters before you compare two results. Repeat-scan variability for arm fat runs roughly 4% to 8.5% in DXA studies, compared with about 1% to 2% for total body fat, so small changes between scans may be nothing at all.

  • Scan-to-scan noise: same-day repeat DXA scans showed arm fat variability of 8.46% in people with inflammatory arthritis, 7.8% in elite wheelchair athletes, and about 4.3% in one general segmental measurement study.
  • What you did beforehand: hard exercise plus unrestricted eating and drinking before a DXA scan shifted regional estimates and raised measurement error by about 10%. Fasted, rested scans are more reliable.
  • Positioning and body size: where your arms sit relative to your trunk affects how software splits regions, and even a pillow can change soft-tissue readings. Higher BMI and thicker tissue also increase error.
  • Method and machine: DXA, bioelectrical impedance, and skinfolds measure related but different things. Results from different machines or methods should not be treated as directly comparable.

Tracking Your Trend

Given that noise, a trend is the cleanest way to read this number. Get a baseline. If you are deliberately changing your diet, training, or medication, rescan after 3 to 6 months, then at least once a year after that. Use the same method, device, facility, and preparation whenever you can.

Read changes in context. A drop in arm fat matters most when arm lean mass holds steady or rises, which means the ratio is improving. A drop in both fat and muscle can mean weight is coming off the wrong way. Most trials of diet, exercise, and medication measured whole-body fat or combined limb fat rather than arms alone, so your own repeated measurements are the most direct evidence of what is happening in this region.

What to Do With an Unexpected Result

Start by reading arm fat against the other numbers on the same report: arm lean mass, total body fat, and visceral fat. Then add bloodwork, because a body-composition result shows where tissue is stored but not what it is doing to your metabolism. Fasting insulin, glucose, HbA1c, ApoB, and ALT fill in that picture. HbA1c tracks average blood sugar over about three months. ApoB counts cholesterol-carrying particles. ALT is a liver enzyme that can rise when fat builds up in the liver.

  • High arm fat, low arm muscle: this is the pattern most studies flag. Prioritize the blood markers above and rescan in 3 to 6 months to see whether the ratio moves.
  • High arm fat plus high visceral fat and rising insulin or HbA1c: this combination points to established insulin resistance. If lifestyle changes are not moving the numbers, an obesity medicine specialist or endocrinologist can go over prescription options with you.
  • Arm fat falling when you are not trying, especially past 60 or with a chronic illness: look for the cause. Unexplained loss of fat and muscle reserves warrants a physician visit.
  • High arm fat with normal labs, low visceral fat, and good muscle: this is likely lower priority. Keep tracking the trend instead of reacting to one result.

If you have recently started a medication known to cause weight gain, such as an antipsychotic or certain antidepressants, repeat the same type of measurement a few months in, so any change is caught early and can feed into the conversation with whoever prescribes it.

What Moves This Biomarker

Evidence-backed interventions that affect your Fat Mass (Arms) level

↓ Decrease
Use GLP-1 based medication such as liraglutide, semaglutide, or tirzepatide when appropriate
These drugs usually lower fat mass, and limb fat can fall as part of that change. In a 24-week randomized trial of 85 adults with type 2 diabetes and fatty liver disease, liraglutide cut combined arm-and-leg fat by about 1.5 to 2 pounds more than the comparison drug gliclazide. The trial reported arms and legs together, so the arm-only change was not measured.
MedicationModerate Evidence
↓ Decrease
Do regular aerobic exercise, alone or combined with strength training
Regular training reduces total fat, and adding strength work helps protect or build the muscle on the other side of your fat-to-muscle ratio. In a randomized trial of adults with overweight or obesity, aerobic training cut fat mass and body weight most, while combined aerobic and resistance training was needed to also add lean mass. These trials measured whole-body fat, so the arm-specific change is inferred.
ExerciseModerate Evidence
↓ Decrease
Eat in a sustained calorie deficit, either continuously or with structured diet breaks
A sustained calorie deficit reduces fat mass, and arm fat usually falls as part of whole-body fat loss. In a randomized trial of 30 women with obesity, both continuous calorie restriction and a version with planned refeeds and diet breaks reduced fat mass. These studies measured whole-body fat or weight, not arm fat specifically.
DietModerate Evidence
↑ Increase
Take antipsychotic medications such as olanzapine, clozapine, or risperidone
Several antipsychotics cause real weight and fat gain, which can push arm fat up over time. Randomized trials found the greatest weight gain with chlorpromazine, clozapine, olanzapine, and zotepine, and cohort data show at least 7% weight gain with several agents, including olanzapine, clozapine, risperidone, quetiapine, and aripiprazole. These studies measured body weight and metabolic markers rather than arm fat directly.
MedicationModerate Evidence
↓ Decrease
Take metformin, a daily pill that lowers blood sugar
Metformin can lower limb fat in people with type 2 diabetes and fatty liver disease. In the same 24-week randomized trial, metformin lowered combined arm-and-leg fat by about 1.5 to 2 pounds more than gliclazide. Arms were not reported separately from legs.
MedicationModest Evidence
↑ Increase
Take SSRI antidepressants or tricyclic antidepressants long term
Long-term use of many antidepressants can add body weight and waist size, which can push arm fat up over time. In a community cohort of about 2,500 adults, sustained SSRI or tricyclic use was linked to steeper rises in BMI and waist size, which returned toward baseline after stopping. Arm fat was not measured directly.
MedicationModest Evidence

Frequently Asked Questions

References

50 studies
  1. Ningjian Wang, Ying Sun, Haojie Zhang, Chi Chen, Yuying Wang, Ji-hui Zhang, Fangzhen Xia, Christian Benedict, Xiao Tan, Yingli LuJournal of Cachexia, Sarcopenia and Muscle2021
  2. Rui Zhou, Hao-wen Chen, Yang Lin, Fu-rong Li, Qi Zhong, Yi-ning Huang, Xian-bo WuJournal of the American Heart Association2023
  3. Jie Guo, Yuxia Wei, Emerald G. Heiland, a. MarsegliaJournal of Cachexia, Sarcopenia and Muscle2024
  4. Xin-ming Xu, Yi Guo, Li-Li Huang, Berty Ruping Song, Dan Chen, Fan Weng, Xueying Zheng, Yu-feng Wen, Zhenyu Wu, Xiang Gao, Liang SunObesity2024